Ecoppia Scientific Ltd reported earnings results for the third quarter and nine months ended September 30, 2021. For the third quarter, the company reported sales was USD 1.58 million compared to USD 0.295 million a year ago. Net loss was USD 3.58 million compared to USD 13.03 million a year ago. Basic loss per share from continuing operations was USD 0.04 compared to USD 0.48 a year ago.
For the nine months, sales was USD 5.53 million compared to USD 0.968 million a year ago. Net loss was USD 8.73 million compared to USD 17.85 million a year ago. Basic loss per share from continuing operations was USD 0.09 compared to USD 0.53 a year ago.